Advances in the Treatment of Metastatic Prostate Cancer
Mayo Clinic Proceedings(2015)
摘要
During the past several years, there has been substantial progress in the development of treatments for advanced prostate cancer with the approval of multiple new life-prolonging agents using different mechanisms of action. Such progress was attainable because of advances in our understanding of the biology behind mechanisms of androgen receptor pathway activation, complex tumor-microenvironment interaction of bone metastasis, antitumor immunology, and new oncogenic pathways. Continuous efforts are being made to develop new therapeutics with novel mechanisms of action, define the optimal sequences and/or combinations of current agents, and identify reliable surrogate end points to facilitate new drug development.
更多查看译文
关键词
AA,ADT,AR,AR-V,CRPC,CTC,CYP,FDA,LBD,mCRPC,OS,PAP,PD-1,PD-L1,PSA,rPFS,SRE,TAA,ZA
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要